Novo Nordisk A/S ADR (NY: NVO )

105.06 +2.43 (+2.37%)
Official Closing Price Updated: 7:00 PM EST, Nov 22, 2024 Add to My Watchlist

Other Filings

Form 6-K
Source: SEC/Edgar
October 01, 2013
Form 6-K
Source: SEC/Edgar
October 01, 2013
Form 6-K
Source: SEC/Edgar
September 25, 2013
Form 6-K
Source: SEC/Edgar
September 16, 2013
Form 6-K
Source: SEC/Edgar
September 09, 2013
Form 6-K
Source: SEC/Edgar
September 03, 2013
Form 6-K
Source: SEC/Edgar
September 03, 2013
Form 6-K
Source: SEC/Edgar
September 02, 2013
Form 6-K
Source: SEC/Edgar
September 02, 2013
Form 6-K
Source: SEC/Edgar
August 19, 2013
Form 6-K
Source: SEC/Edgar
August 07, 2013
Form 6-K
Source: SEC/Edgar
August 06, 2013
Form 6-K
Source: SEC/Edgar
July 22, 2013
Form 6-K
Source: SEC/Edgar
July 14, 2013
Form 6-K
Source: SEC/Edgar
July 07, 2013
Form 6-K
Source: SEC/Edgar
July 04, 2013
Form 6-K
Source: SEC/Edgar
June 30, 2013
Form 11-K
Source: SEC/Edgar
June 27, 2013
Form 20-F/A
Source: SEC/Edgar
June 27, 2013
Form 11-K
Source: SEC/Edgar
June 25, 2013
Form 6-K
Source: SEC/Edgar
June 23, 2013
Form 6-K
Source: SEC/Edgar
June 18, 2013
Form 6-K
Source: SEC/Edgar
June 17, 2013
Form 6-K
Source: SEC/Edgar
June 10, 2013
Form 6-K
Source: SEC/Edgar
June 03, 2013
Form 6-K
Source: SEC/Edgar
June 02, 2013
Form 6-K
Source: SEC/Edgar
May 30, 2013
Form 6-K
Source: SEC/Edgar
May 27, 2013
Form 6-K
Source: SEC/Edgar
May 23, 2013
Form 6-K
Source: SEC/Edgar
May 21, 2013
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.